首页> 外文OA文献 >Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma

【2h】

Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma

机译：利用变异型人α-胎蛋白启动子在肝细胞癌基因治疗中的α-胎蛋白启动子

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H Ishikawa; K Nakata; F Mawatari; T Ueki; S Tsuruta; A Ido; K Nakao; Y Kato; N Ishii; K Eguchi;
展开▼
作者单位

展开▼
年度 1999
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma. [J] . Ishikawa H, Nakata K, Mawatari F, Gene therapy . 1999,第4期

机译：人α甲胎蛋白启动子的变异型在靶向肝细胞癌的基因治疗中的应用。
2. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study [J] . Wei Li, Dao-Ming Li, Kai Chen, BMC Cancer . 2012,第1期

机译：使用甲胎蛋白启动子增强剂和pgk启动子开发针对肝细胞癌的基于蛋白磷酸酶2A抑制的基因治疗策略的开发：一项体内外研究
3. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. [J] . Willhauck MJ, Sharif-Samani BR, Klutz K, Gene therapy . 2008,第3期

机译：针对甲胎蛋白启动子的碘化钠碘转运体基因治疗肝细胞癌。
4. Specifically Deoxyribozyme of the PTPRO gene as a potential gene therapy means for human hepatocellular carcinoma [C] . Chunnian Su, Min Yu International Conference on Chemical Engineering and Advanced Materials . 2013

机译：PTPro基因的脱氧性作为人类肝细胞癌的潜在基因治疗方法
5. Mechanistic Study of the Effect of CDH1 Promoter Hypermethylation on Drug Resistance and Related Gene Expression in Multidrug Resistant Human Hepatocellular Carcinoma R-HepG2 Cells. [D] . Jiang, Lei. 2010

机译：CDH1启动子甲基化对多药耐药人肝细胞癌R-HepG2细胞耐药性及相关基因表达影响的机理研究。
6. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study [O] . Wei Li, Dao-Ming Li, Kai Chen, 2012

机译：使用甲胎蛋白启动子增强剂和pgk启动子开发针对肝细胞癌的基于蛋白磷酸酶2A抑制的基因治疗策略的开发：体内和体外研究
7. Expression of ?-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy [O] . Souhei Ohguchi, Harushige Nakatsukasa, Toshihiro Higashi, 1998

机译：人肝细胞癌中的β--释肽和白蛋白基因的表达：基因靶向人类肝细胞癌基因治疗中的限制
8. Genetically Targeted Radiotherapy Utilizing the Human Sodium Iodide Symporter in Human Breast Carcinoma Cells [R] . Krager, K. 2007

机译：在人乳腺癌细胞中利用人体钠碘化物转运的基因靶向放射治疗

Utilization of variant-type of human α-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅